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The failure to reinvest demyelinated axons with new myelin sheaths 
results in a lack of axonal conduction and metabolic support. This 
ultimately leads to irreversible axonal loss, which typifies later 
stages of chronic demyelinating diseases such as multiple sclerosis 
(MS), leaving patients with permanent neurological disability1,2. 
Remyelination frequently occurs in the context of innate and adap-
tive immune responses3,4. T cells can act as effectors of myelin dam-
age but are also required for successful remyelination5. However, 
T cells encompass a range of phenotypically and functionally distinct 
subsets, and the contributions of T cell subsets to CNS remyelination 
are poorly understood. Since inflammation-resolving effects of Treg 
frequently coincide with tissue regeneration, we hypothesized that 
Treg promote remyelination.
RESULTS
Treg cells are required for efficient oligodendrocyte progenitor 
cell differentiation during remyelination in vivo.
To study regenerative T cell functions in remyelination in vivo, as dis-
tinct from classical T cell-mediated demyelination observed in experi-
mental autoimmune encephalomyelitis (EAE), focal demyelination 
was induced by injecting lysolecithin into spinal cord white matter of 
mice. Such lesions naturally remyelinate within 1 month and follow 
a well-defined time-course with distinct phases of oligodendrocyte 
progenitor cell (OPC) activation, recruitment and oligodendrocyte 
differentiation6,7. Flow cytometric immunophenotyping 3 d post 
lesioning (d.p.l.) demonstrated an abundance of CD45+CD11b+ 
myeloid cells in lesioned tissue, as previously described8. However, 
distinct (albeit smaller) populations of CD3+ and CD4+ T cells were 
also evident even up to 11 d.p.l., including CD3+CD4+Foxp3+ Treg, 
a T cell population recently implicated in tissue regeneration9,10 
(Supplementary Fig. 1a–e). To determine whether Treg were func-
tionally important in remyelination, we used Foxp3-DTR trans-
genic mice in which diphtheria toxin (DT) administration depletes 
Foxp3-expressing cells11 (Supplementary Fig. 1f). Chronic DT expo-
sure causes toxicity and considerable morbidity even in wild-type 
mice12–14, while Treg deficiency induces systemic immune activation11, 
precluding long-term studies. Therefore, densities of CC1+Olig2+- 
differentiated oligodendrocytes, a surrogate readout of remyelina-
tion15, were compared at 14 d.p.l., and electron microscopy was 
performed at 17 d.p.l.
Treg-depleted animals exhibited significantly fewer differentiated 
CC1+Olig2+ oligodendrocytes than nondepleted animals or DT-
treated wild-type controls (Fig. 1a,b). Mice lacking Treg exhibited 
comparable lesion sizes (Fig. 1c), indicating that Treg were not required 
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Regeneration of CNS myelin involves differentiation of oligodendrocytes from oligodendrocyte progenitor cells. In multiple 
sclerosis, remyelination can fail despite abundant oligodendrocyte progenitor cells, suggesting impairment of oligodendrocyte 
differentiation. T cells infiltrate the CNS in multiple sclerosis, yet little is known about T cell functions in remyelination.  
We report that regulatory T cells (Treg) promote oligodendrocyte differentiation and (re)myelination. Treg-deficient mice exhibited 
substantially impaired remyelination and oligodendrocyte differentiation, which was rescued by adoptive transfer of Treg.  
In brain slice cultures, Treg accelerated developmental myelination and remyelination, even in the absence of overt inflammation. 
Treg directly promoted oligodendrocyte progenitor cell differentiation and myelination in vitro. We identified CCN3 as a Treg-derived  
mediator of oligodendrocyte differentiation and myelination in vitro. These findings reveal a new regenerative function of Treg in 
the CNS, distinct from immunomodulation. Although the cells were originally named ‘Treg’ to reflect immunoregulatory roles,  
this also captures emerging, regenerative Treg functions.
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Figure 1 Treg are required for efficient OPC differentiation and remyelination in vivo. (a) Immunohistochemical analysis of CC1+Olig2+ cells per lesion 
area in spinal cords of Foxp3-DTR and C57BL/6 mice at 14 d.p.l.; n = 6 control mice and n = 5 Treg-depleted (−Treg) mice (t = 2.703, d.f. = 9, *P = 0.0243;  
t = 5.624, d.f. = 9, ***P = 0.0003). (b) Representative images of a showing demyelination by Luxol fast blue staining (scale bar, 200 µm) and 
CC1+Olig2+ cells in lesions (scale bar, 100 µm; green, Olig2+ cells; red, CC1+ cells; blue, DAPI). Rightmost panels: merged images. (c) Lesion size of 
Foxp3-DTR mice ± DT at 5 d.p.l. (n = 5 mice per group; t = 1.773, d.f. = 8, P = 0.1142). (d) Olig2+Ki67+ cells per lesion area in spinal cords of Foxp3-
DTR mice at 5 d.p.l. (n = 5 mice per group; t = 0.7789, d.f. = 8, P = 0.4584). (e) Left: electron micrographs showing distribution of remyelinated 
axons vs. unmyelinated axons in spinal cord lesions of control or Treg-depleted mice at 17 d.p.l. Scale bar, 5 µm (top) and 1 µm (bottom). Middle: three 
mice per group were analyzed. Right: data represent mean ± s.e.m. from 109 micrographs from 3 mice per group (two-tailed Mann-Whitney U-test; U = 2,  
P < 0.0001). (f) CC1+Olig2+ cells per lesion area in spinal cords of DT-treated Foxp3-DTR mice with or without adoptively transferred Treg at 14 d.p.l.  
(n = 15 Treg-depleted mice and n = 8 Treg-depleted and adoptively transferred Treg mice pooled from two independent experiments; t = 2.353, d.f. = 21, 
P = 0.0285). (g) Representative flow cytometric identification of adoptively transferred Treg in lymph nodes of Treg-injected mice from f and controls, 
gated on CD4+ cells (gray box, Foxp3+ cells; colors indicate density of events, ranging from low (blue) to high (red) density). (h) Immunohistochemical 
analysis of CC1+Olig2+ cells per area of the corpus callosum 2 weeks after cuprizone withdrawal (n = 5 mice per group; data represent analysis of 
1–2 regions of corpus callosum per mouse; t = 2.693, d.f. = 8, P = 0.0274). (i) Representative images of h. Top: Black Gold II myelin stain. Bottom: 
Olig2+CC1+ cell staining (green, Olig2+ cells; red, CC1+ cells; scale bar, 100 µm). Data shown are representative of 4 (a and b), 2 (c, d, f and g) and 1 
(e, h and i) independent biological experiments. Data presented with mean values as indicated; error bars show s.e.m.; unpaired two-tailed Student’s  
t-test, unless otherwise indicated above. *P < 0.05, ***P < 0.001; n.s., not significant.
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to limit tissue damage in this model and, notably, that experimental 
groups had comparable burdens of demyelination to repair. Reduced 
numbers of CC1+Olig2+ cells in Treg-depleted mice could have arisen 
because of a failure to recruit sufficient OPC to the demyelinated 
area. However, no significant differences in Olig2+Ki67+-proliferat-
ing OPC at 5 d.p.l. or 10 d.p.l. were observed between groups (Fig. 1d 
and Supplementary Fig. 1g), indicating that reduced generation of 
oligodendrocytes was likely due to impairment in differentiation. 
Restricting Treg depletion only to the prelesioning phase did not alter 
CC1+Olig2+ cell numbers (Supplementary Fig. 1h), suggesting that 
Treg were important in later stages of remyelination. Indeed, elec-
tron microscopic analysis of lesions demonstrated significantly fewer 
remyelinated axons in Treg-depleted animals (Fig. 1e). To further 
test the role of Treg in remyelination using a gain-of-function model, 
magnetic-activated cell sorting (MACS)-purified wild-type Treg were 
injected into Treg-deficient animals (‘injected Treg’). Treg administration 
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Figure 2 Treg directly promote brain tissue myelination and remyelination ex vivo. (a–c) Analysis of (a) MBP+ cells and (b) myelination index per field of 
view (FOV) in brain stem slices treated with control media or Treg-conditioned media. (c) Representative images taken from z-stacks at 7 d.i.v. (scale bar, 
100 µm; green, neurofilament-200 (NF200); red, MBP). Control: MBP+ counts, n = 17 FOV and myelination index, n = 8 FOV. Treg: MBP+ counts,  
n = 8 and myelination index, n = 12 FOV. FOVs were selected from 3 or 4 slices per group (MBP+ counts: U = 28.5, P = 0.0196, two-tailed Mann-
Whitney U-test; myelination index: t = 2.886, d.f. = 18, P = 0.0098, unpaired two-tailed Student’s t-test). (d–f) Analysis of (d) MBP+ cells and (e) 
myelination index per FOV in control, demyelinated and remyelinating brain stem slices. (f) Representative images taken from z-stacks (scale bar, 100 µm;  
green, NF200; red, MBP). Control: MBP+ counts, n = 15 FOV and myelination index, n = 10 FOV. Demyelination: MBP+ counts, n = 6 FOV and 
myelination index, n = 6 FOV. Remyelination control: MBP+ counts, n = 5 FOV and myelination index, n = 20 FOV. Remyelination + Treg: MBP+ counts, 
n = 26 and myelination index, n = 32 FOV. Fields of view were selected from 3–6 slices per group (MBP+ counts: demyelination, U = 0, P < 0.0001; 
remyelination, U = 0, P < 0.0001; two-tailed Mann Whitney U-test; myelination index: demyelination, U = 9, P = 0.0225; two-tailed Mann Whitney  
U-test, remyelination, t = 5.845, d.f. = 50, P = 0.001; unpaired two-tailed Student’s t-test). (g–i) Analysis of (g) MBP+ cells and (h) myelination index 
per FOV in brain stem slices. (i) Representative images taken from z-stacks (scale bar, 100 µm; green, NF200; red, MBP). Control: MBP+ counts,  
n = 11 FOV and myelination index, n = 10 FOV. Treg: MBP+ counts, n = 13 and myelination index, n = 12 FOV. FOVs were selected from 3–6 slices per 
group (MBP+ counts: t = 7.537, d.f. = 22, P < 0.0001; myelination index: t = 2.334, d.f. = 20, P = 0.0301, unpaired two-tailed Student’s t-tests). 
Data shown are representative of 6 (a–c) and 2 (d–f and g–i) independent experiments. Data presented with mean values as indicated; error bars 
indicate s.e.m.; *P < 0.05, **P < 0.01, ***P < 0.001.
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significantly increased numbers of CC1+Olig2+-differentiated 
oligodendrocytes in lesions, demonstrating the capacity of Treg to 
rescue impaired oligodendrocyte differentiation in vivo (Fig. 1f,g). 
To verify the importance of Treg in myelin regeneration in a second 
remyelinating model, as well as at a different CNS site, demyelina-
tion was induced using cuprizone. Similarly to results obtained using 
the spinal cord lysolecithin model, Treg depletion significantly 
impaired CC1+Olig2+ oligodendrocyte differentiation in the corpus 
callosum of cuprizone-treated mice at day 14 of the remyelina-
tion phase (Fig. 1h,i) but not at day 10 (Supplementary 1i). 
This finding was supported by reduced Plp1 mRNA expression in Treg-
depleted animals at day 14 (Supplementary Fig. 1j). Treg-depletion 
did not significantly affect overall oligodendrocyte lineage numbers 
(Supplementary Fig. 1k; P = 0.2857 at day 10 and P = 0.1273 at day 
14), emphasizing the predominant effect of Treg-depletion on the dif-
ferentiation phase of the regenerative response. To our knowledge, 
these studies identify a novel functional role for Treg in the process 
of oligodendrocyte differentiation and CNS remyelination in both 
brain and spinal cord in vivo.
Treg directly promote brain tissue myelination and 
remyelination ex vivo.
Next, we asked if Treg exerted direct regenerative effects within 
CNS tissue, distinct from immunomodulation of infiltrating immune 
cells. To this end, we used neonatal murine organotypic brain slice 
cultures that naturally generate compact myelin ex vivo via OPC pro-
liferation, differentiation and axonal ensheathment16–19. To deter-
mine whether Treg influenced myelination, fluorescence-activated cell 
sorting (FACS)-purified CD4+Foxp3-eGFP+ natural Treg or control 
CD4+Foxp3– conventional T cells were added directly onto slices. 
T cells infiltrated tissues and GFP+ Treg were still detectable 
within slices after 3 d in vitro (d.i.v.) (Supplementary Fig. 2a). Slices 
co-cultured with Treg cells contained significantly more MBP+ oli-
godendrocytes and had significantly higher myelination index (mye-
lin and axonal overlap, representing axonal ensheathment by myelin) 
at 3 d.i.v. than control slices without added cells (Supplementary 
Fig. 2b–d; P = 0.0041 and P = 0.0033) or slices with conventional 
T cells (Supplementary Fig. 2e; P = 0.0006). These findings demon-
strate a myelinating action induced specifically by Treg, rather than 
by activated T cells in general.
To investigate mechanisms of Treg-induced myelination beyond 
cell–cell contact, slices were supplemented either with control medium 
or with conditioned media from CD4+ T cells that were polarized 
to a Treg phenotype or that were nonpolarized to serve as activated 
T cell controls (Supplementary Fig. 2f). Treg-conditioned media sig-
nificantly increased MBP+ mature oligodendrocytes and myelination 
compared to controls at 7 d.i.v. (Fig. 2a–c and Supplementary Fig. 2g). 
These findings indicated that secreted factors drive oligodendrocyte 
differentiation and promyelinating effects of Treg.
To test if Treg also promoted regeneration of myelin, slices were 
myelinated in culture for 14 d and were then demyelinated with lysol-
ecithin for 16 h. Addition of Treg-conditioned media for 7 d following 
demyelination significantly increased MBP+ mature oligodendrocytes 
(Fig. 2d,f) and myelination index (Fig. 2e,f and Supplementary 
Videos 1 and 2) compared to controls. These increases represented 
an acceleration of remyelination by Treg, as control slices eventually 
remyelinated after 2 weeks (data not shown). This was confirmed 
by electron microscopy showing significantly increased numbers of 
remyelinated axons in Treg-treated slices compared to control remyeli-
nating slices (Supplementary Fig. 2h–j; P = 0.0016 and P = 0.0381).
Although brain slices lack peripheral immune cells, CNS-resident 
microglia and astrocytes can generate local inflammatory responses 
upon slicing and demyelination20,21, and therefore, effects of Treg on 
(re)myelination could be due to known anti-inflammatory func-
tions. Thus, to categorically test whether Treg directly promoted CNS 
myelination rather than indirectly via immunoregulation, slices were 
equilibrated for 1 week after slicing to allow proinflammatory cytokine 
production to subside20 (Supplementary Fig. 2k) before addition of 
T cell-conditioned media for 7 d. In this model, slices treated with 
Treg-conditioned media again exhibited significantly higher MBP+ 
oligodendrocyte numbers (Fig. 2g,i) and myelination index (Fig. 2h,i) 
than controls. These findings show that Treg directly promoted 
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Figure 3 Treg directly enhance oligodendrocyte differentiation and myelination in vitro. (a–d) Immunofluorescence analysis of (a) MBP+ cell numbers  
(t = 8.200, d.f. = 10, P < 0.0001), (b) percentage area (U = 0, P = 0.0022), (c) total Olig2+ cell numbers (t = 0.8294, d.f. = 10, P = 0.4263) and (d) 
representative images of mixed glial cultures analyzed (scale bar, 100 µm; green, Olig2; red, MBP; n = 6 wells). (e,f) Immunofluorescence analysis of 
(e) Olig2+Ki67+ cell numbers (t = 1.299, d.f. = 10, P = 0.2230) with (f) representative images of mixed glial cultures (scale bar, 100 µm; green,  
Olig2; red, Ki67, n = 6 wells). (g,h) Immunofluorescence analysis of (g) MBP+ cell numbers (t = 6.431, d.f. = 22, P < 0.0001) and (h) representative 
images of pure OPC cultures analyzed (scale bar, 50 µm; red, MBP; blue, DAPI, n = 12 FOVs). (i,j) Immunofluorescence analysis of (i) MBP+CC1+cell 
numbers (n.d., not detectable) and (j) representative images of DRG neuron–OPC cocultures in the presence or absence of Treg-conditioned medium  
(n = 20 fields of view; scale bars, 50 µm and 20 µm (enlarged image); red, MBP; green, CC1; blue, DAPI). Data shown are representative of at least 12 
(a, b and d), 3 (c and g–j) and 2 (e and f) independent experiments. Data presented with mean values as indicated; error bars show s.e.m.; unpaired 
two-tailed Student’s t-test (cell counts) and Mann-Whitney U-tests (percentage area); ** P < 0.01, *** P < 0.001; n.s., not significant.
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oligodendrocyte differentiation and myelin production under mini-
mally inflammatory conditions, suggesting a primary regenerative 
function of Treg in the CNS distinct from, but complementary to, 
known immunomodulatory functions.
Treg directly enhance oligodendrocyte differentiation and 
myelination in vitro.
To further investigate mechanisms of Treg-induced remyelination via 
OPC differentiation, we next determined whether Treg directly influenced 
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Figure 4 CCN3 is produced by Treg and promotes oligodendrocyte differentiation and myelination. (a) ELISA quantification of CCN3 in T cell-
conditioned media; n = 4 independently generated supernatants using different mice (U = 0, P = 0.0294, two-tailed Mann-Whitney U-test).  
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d.f. = 10, P = 0.0001; unpaired two-tailed Student’s t-test; Treg vs. Treg + IgG: U = 10, P = 0.2207; Mann-Whitney U-test) and (d) MBP+ percentage 
area in mixed glial cultures, n = 6 wells (control vs Treg: U = 0, P = 0.0022; Treg vs. Treg + aCCN3: U = 0, P = 0.0022; Treg vs. Treg + IgG: U = 18, P = 1; 
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condition; n = 13 FOV for IgG-eluted condition). FOVs were from 3 or 4 slices per group (control vs. Treg: t = 5.378, d.f. = 38, P < 0.0001; Treg vs. 
CCN3-depleted: t = 4.159, d.f. = 38, P = 0.0002; CCN3-depleted vs. IgG-depleted: t = 4.446, d.f. = 38, P < 0.0001; unpaired two-tailed Student’s 
t-test; CCN3-eluted vs. IgG-eluted: U = 43, P = 0.0129; two-tailed Mann-Whitney U-test). Scale bar, 100 µm; green, NF200; red, MBP. Data shown are 
representative of at least 4 (a), 2 (b and f–h) and 3 (c–e) independent experiments. Data are presented with mean values as indicated; error bars show 
s.e.m.; *P < 0.05, **P < 0.01, ***P < 0.001.
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glial cells using mixed glial cultures containing OPC as well as astro-
cytes and microglia (Supplementary Fig. 3a). Treatment with Treg-
conditioned media for 5 d significantly increased oligodendrocyte 
differentiation compared to control medium (Fig. 3a,b,d) and control 
nonpolarized T cell-conditioned medium (Supplementary Fig. 3b,c), 
demonstrating direct Treg signaling to glia. This effect was consistent 
independent of whether Treg were induced from total CD4+ T cells 
or from naive CD4+ T cells (Supplementary Fig. 3d). Supporting 
our in vivo findings, we observed no difference in oligodendrocyte 
lineage cell numbers (Fig. 3c), proliferation (Fig. 3e,f) or survival 
(Supplementary Fig. 3e,f).
As proof of principle that Treg can directly modulate a regenera-
tive cell population, independent of other CNS cells, pure OPC were 
cultured in the presence or absence of T cell-conditioned media. 
Within just 2 d, OPC treated with Treg-conditioned media exhibited 
significantly more MBP+ differentiated oligodendrocytes (Fig. 3g,h), 
demonstrating a direct action of Treg on OPC. To test whether this 
was functionally relevant, Treg-conditioned media were added to 
OPC–dorsal root ganglion (DRG) neuron co-cultures. Treg acceler-
ated myelination of DRG neurons, which was evident within 4 d of 
stimulation with Treg-conditioned media (Fig. 3i,j). Although these 
findings do not rule out additional indirect mechanisms, these data 
show that Treg-secreted factors can directly signal to OPC to promote 
oligodendrocyte differentiation and functional myelination. This 
demonstrates for the first time, to our knowledge, that Treg can alter 
the regenerative capacity of CNS progenitor cells.
CCN3 is produced by Treg and promotes oligodendrocyte 
differentiation and myelination
We next investigated Treg-secreted factors that enhanced oligodendro-
cyte differentiation and myelination. Analysis of conditioned media by 
proteome profiling identified a number of candidate factors relevant 
to regeneration (Supplementary Fig. 4a), including CCN3, a growth 
regulatory protein with bioactivity in extracellular, cytoplasmic and 
nuclear compartments and which is implicated in regeneration of var-
ious tissues22–25. Dual enzyme-linked immunosorbent assay (ELISA) 
and western blot validation confirmed that CCN3 was produced 
by Treg (Fig. 4a,b). To determine whether CCN3 mediated the oli-
godendrocyte-differentiating effect of Treg, anti-CCN3 antibody was 
added to glial and brain slice cultures treated with Treg-conditioned 
media for 5 and 7 d, respectively. Anti-CCN3 antibody abolished Treg-
induced oligodendrocyte differentiation in glial cultures (Fig. 4c,d  
and Supplementary Fig. 4b) and inhibited the promyelinating effect 
of Treg in brain slice cultures (Fig. 4e). To confirm these findings with 
a second loss-of-function approach, CCN3 was depleted from Treg-
conditioned media (Supplementary Fig. 4c,d) and recovered as eluted 
protein. Treg-conditioned media depleted of CCN3 failed to promote 
oligodendrocyte differentiation in glial cultures (Fig. 4f) or brain 
slice myelination (Fig. 4g,h). Furthermore, treatment with recov-
ered CCN3 significantly enhanced brain slice myelination (Fig. 4g,h). 
These studies implicate CCN3 as a Treg-derived protein that mediates 
Treg-driven OPC differentiation and CNS myelination.
DISCUSSION
Immune-mediated tissue regeneration is an expanding field, and 
recent studies highlight the importance of innate immune signal-
ing in myelin regeneration3,4,26. Yet despite decades of research into 
T cell-mediated pathogenesis and immunomodulation of CNS 
demyelination, very little is known about T cell functions in remy-
elination. Given that T cell-targeting therapies are used in MS, it is 
crucial to understand the full range of roles played by T cells. However, 
when interrogating regenerative immune functions, appropriate 
choice of experimental models is crucial. Treg limit damage in many 
inflammatory disease models, including EAE. Overlapping tissue 
damage and regeneration often occur in immune-mediated disease 
models such as EAE. Thus, true enhancement of regeneration can be 
challenging to distinguish from modulation of immunopathogenicity 
in these models. This motivated our choice of lysolecithin-induced 
demyelination, in which the demyelinating insult is time-limited, 
clearly defined anatomically, independent of immune-driven tissue 
damage and follows a well-defined course of highly efficient myelin 
regeneration. With this approach, in combination with other mod-
els without peripheral immune influence, such as OPC and brain 
slice cultures, we have uncovered a key regenerative function of Treg. 
Mechanisms underlying this function include acceleration of oli-
godendrocyte differentiation and (re)myelination, via CCN3, a pro-
tein which, to our knowledge, was not previously known to target 
OPC or indeed to be produced by Treg.
CCN3 is a growth-regulatory protein with bioactivity in extracel-
lular, cytoplasmic and nuclear compartments, and it is implicated in 
regeneration of various tissues23–25,27,28. CCN3 is expressed in the 
developing CNS22,29 and in glioma30, but has not previously been 
implicated in CNS regeneration. Of note, we detected CCN3 expres-
sion in early organotypic brain slice cultures (data not shown); this 
may be developmentally regulated or due to tissue injury. In immune 
development, CD34+ bone marrow progenitor cells express CCN3; 
however, to our knowledge, ours is the first report showing that Treg, 
or indeed any T cell population, produce CCN3. Together, these find-
ings identify CCN3 as an immune-effector molecule from early innate 
immune development to resolution of adaptive immune responses. 
This potentially places CCN3 at the leading edge of immune-medi-
ated tissue regeneration and warrants investigation in immune cells 
at other anatomical sites. Notably, commercially sourced recom-
binant CCN3 did not induce oligodendrocyte differentiation (data 
not shown). This may be due to the lack of critical post-translational 
modifications in recombinant CCN3 and/or the presence of a 10-His 
tag at the C-terminus of the recombinant protein. This tag may impair 
bioactivity of this key functional region of CCN3, which contains a 
cysteine knot motif involved in homo- and heterodimerization. This 
emphasizes the importance of both gain-of-function and loss-of-func-
tion studies of CCN3 in reductionist and more complex models.
Recently, Burzyn et al. identified roles for Treg in muscle regeneration 
associated with local immunomodulation and amphiregulin expres-
sion9, while Arpaia et al. reported T cell receptor (TCR)-independent 
tissue-protective functions of amphiregulin-expressing Treg in influenza- 
infected lungs10. Other studies describe associations of Treg with regen-
eration of cardiac muscle and neurons31–33. Here we identified that 
Treg directly promote oligodendrocyte differentiation and myelin pro-
duction, even in the absence of overt inflammation. Thus, signaling 
from Treg can directly increase the regenerative capacity of a progenitor 
cell population, independent of immunomodulation known to sup-
port regeneration at other anatomical sites. This confers a primary 
regenerative role for Treg complementary to, but distinct from, known 
immunomodulatory functions. In concert, these two functions con-
fer fundamental damage-limiting and damage-resolving roles to Treg. 
Therapies to boost tissue regeneration should consider this emerging 
and central role of Treg in natural regeneration. This knowledge holds 
therapeutic potential for tissue regeneration in diseases such as MS.
Collectively, our findings and recent studies by others show that 
Treg promote regeneration via different factors in different tissues. 
Our regenerative immunology study expands the classical functions 
of Treg beyond regulation to include regeneration.
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METhODS
Methods, including statements of data availability and any associated 
accession codes and references, are available in the online version of 
the paper.
Note: Any Supplementary Information and Source Data files are available in the 
online version of the paper.
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Animals. All mice were on a C57BL/6 background and were bred in-house. 
Foxp3-DTR mice were a kind gift from Prof. Alexander Rudensky (Memorial 
Sloan Kettering Institute, New York) and Foxp3-eGFP mice were a kind gift from 
Prof. B. Malissen34. Experiments used both male and female neonatal P0–P9 
pups and animals from 6–24 weeks from sources above. To deplete Foxp3+ cells 
in Foxp3-DTR mice, diphtheria toxin was administered as described below. All 
animal maintenance and experiments were in compliance with the UK Home 
Office and approved by the University’s Ethical Committee.
treg depletion and induction of lysolecithin-mediated demyelination. Male 
and female mice from 8 to 24 weeks of age were used. To deplete Foxp3+ cells 
in Foxp3-DTR mice, 1 µg DT (Sigma) in 200 µl saline was injected i.p. daily for 
3–4 d before demyelination. For maintenance of Treg depletion, 1 µg DT was 
injected i.p. every third day after the demyelination procedure. Control mice 
were treated with saline. Depletion was routinely confirmed in blood and spleen 
by flow cytometry. L-α-lysophosphatidylcholine (lysolecithin; Sigma) was used 
to induce a focal demyelinated lesion in the spinal cord of mice as described 
previously6,35. In brief, 1.2 µL lysolecithin was injected into the ventral white 
matter of the lower thoracic spinal cord between vertebrae T11–12 or T12–13. 
At indicated timepoints, mice were terminally anesthetized with ketamine/
Rompun, transcardially perfused with 4% paraformaldehyde in PBS or PBS alone 
(for flow cytometry studies), and the spinal cord tissue was dissected.
Adoptive transfer of wild-type treg into treg-depleted FoxP3-dtR mice. 
FoxP3-DTR mice were treated with DT as described above. In the 24 h before 
lysolecithin-induced demyelination, mice were injected i.p. with 1 × 106 MACS-
purified Treg from wild-type mice that were insensitive to DT treatment, using a 
CD4+ T cell isolation kit (Stemcell Technologies).
tissue processing. For immunohistochemistry, spinal cord tissue was postfixed 
for 2–4 h in 4% PFA and immersed in 20% sucrose in PBS solution overnight. 
For cryopreservation, spinal cords were embedded with OCT medium (VWR) 
and nonconsecutive 12-µm thick cryosections from the approximate center of 
lesions were mounted on glass slides4.
Immunofluorescence staining of cnS tissue. After blocking with 10% goat 
serum (Vector Laboratories), spinal cord sections were incubated with antibodies 
for APC (1:100; clone CC1, Abcam), Ki67 (1:200; clone SoIA15, eBioscience) and 
Olig2 (1:200; cat. no. AB9610, Millipore) overnight. Secondary antibodies goat 
anti-rabbit AF488 (1:200; cat. no. A-11008, Life Technologies) and goat anti-rat 
AF594 (1:200; cat. no. A-11007, Life Technologies) were incubated for 1 h at RT 
(18–23 °C). For CC1 detection, acidic antigen retrieval was performed and a 
mouse-on-mouse immunodetection kit was used (Vector Laboratories). Nuclei 
were counterstained with DAPI before coverslipping with ProLong Gold Antifade 
(Life Technologies). Spinal cord images were acquired on a Leica DM5500 epi-
fluorescence microscope.
luxol fast blue staining of spinal cord tissue. Tissue was placed in 1:1 alcohol:
chloroform solution for 10 h before dehydration in alcohol and incubation in 
0.1% Luxol fast blue solution (Sigma) at 56 °C for 16 h. Tissue was rinsed and 
differentiated in 0.05% lithium carbonate solution for 30 s, followed by 70% alco-
hol for 30 s. After washing with distilled water, tissue was differentiated in 95% 
alcohol and twice in 100% alcohol (each 5 min) before immersing twice in xylene 
for 5 min and coverslipping.
electron microscopy of spinal cord lesions. Animals were perfused with 3% 
glutaraldehyde, 2% paraformaldehyde, 0.1 M phosphate buffer (pH 7.4) and 
0.7% (w/v) NaCl, and spinal cords were dissected and postfixed overnight. 
Specimen were postfixed in 1% osmium tetroxide (Agar Scientific, Stansted, 
UK), dehydrated, stained en bloc with uranyl acetate (Agar Scientific, Stansted, 
UK) and embedded in Durcupan resin (Sigma-Aldrich, UK). Ultrathin sections 
(70 nm) were cut on a Leica UCT ultramicrotome with a Diamond knife 
(Diatome), mounted on formvar-coated copper grids (Electron Microscopy 
Science) and counterstained with uranyl acetate and lead citrate. Random elec-
tron micrographs (109 micrographs from 3 mice per group) were taken from the 
lesions with an FEI Spirit transmission microscope with a Gatan Orius SC200B 
Camera. A total of 3,399 control axons and 2,076 axons from Treg-depleted 
lesions were analyzed blindly.
Flow cytometric immunophenotyping. Fresh spinal cord tissue was dissected 
following transcardial perfusion with PBS, weighed and placed in Neuro Medium 
(Miltenyi Biotec). Medium was removed, tissues were individually passed through 
70-µm strainers and washed with 30% Percoll to pellet cells, and the myelin- 
containing supernatant was carefully removed. Cells were resuspended in 200 µL 
flow cytometry staining buffer (FCSB; 1% FCS, 0.01% NaN3 in PBS) before 
cell surface staining with antibodies to CD45 (clone 104; 1:400), CD11b (clone 
M1/70; 1:400), CD3 (clone 145-2C11; 1:200) and CD4 (clone GK1.5; 1:200), all 
from eBioscience. Foxp3 expression was determined in fresh cells from Foxp3-
eGFP or Foxp3-GFP-DTR mice. To calculate cell numbers, singlets were identi-
fied by FSC-H versus FSC-A, and CD45+ cells were gated for subsequent analyses 
of CD11b, CD3, CD4 and Foxp3-eGFP. Data were acquired on a FACSCanto II 
and analyzed using FlowJo software.
cuprizone-induced demyelination. Eleven-week-old male C57BL/6 and FoxP3-
DTR mice were fed 0.2% cuprizone (bis(cyclohexanone) oxaldihydrazone). Food 
(Teklad Custom Diet TD.140804, Envigo) and water were available ad libitum. 
Cuprizone feeding was maintained for 25 d to induce demyelination. Diet was 
then changed to normal rodent chow for additional 2 weeks to allow remyelina-
tion to occur. To deplete Treg, mice were injected with DT (0.04g DT/kg) or vehicle 
on day 24 and day 25. Treg depletion was maintained by DT administration every 
3 d. Mice were killed for analysis on day 39 and were perfused transcardially with 
PBS followed by cold 4% paraformaldehyde. Brains were removed, postfixed 
overnight in 4% paraformaldehyde and cryoprotected in 30% sucrose. Coronal 
frozen sections of 20 µm thickness were cut using a Leica cryostat. Sections 
between 1 mm and −1 mm relative to bregma were collected and stained for 
CC1 and Olig2 as described above. The number of mature oligodendrocytes 
in the corpus callosum was quantified on images of 1 or 2 sections per animal 
with 5 animals per group. Images of the midline segment of the corpus callosum 
from frontal and middle sections were used to delineate the area for analysis of 
Olig2+CC1+ cells.
Black gold II staining. Tissue sections were stained with Black Gold II (AG105, 
Millipore Corp, Billerica, MA) according to the manufacturer’s instructions. 
Briefly, sections were washed in water, immersed in prewarmed Black Gold II 
solution and incubated at 60 °C for 15 min, followed by transfer into prewarmed 
1% sodium thiosulfate at 60 °C for 5 min. Slides were rinsed three times, dehy-
drated, immersed in xylene for 2 min and coverslipped with mounting media.
gene expression analyses. For qPCR, total RNA was extracted from cerebella 
of perfused mice with an RNeasy FFPE kit (Qiagen) using a modified protocol. 
Tissue was homogenized in supplied PKD buffer before treatment with proteinase 
K. All subsequent steps were followed according to the manufacturer’s instructions. 
RNA purity and concentration was assessed by Nanodrop spectrophotometry. 
Samples were treated with DNase I (Invitrogen) before reverse transcription with 
Superscript IV (Invitrogen). cDNA samples were assayed in triplicate by qPCR 
using Fast SYBR Green (ThermoFisher Scientific) on a Roche LightCycler 480 sys-
tem. Relative gene expression of Plp1 was determined with the Pfaffl method using 
Gapdh as the internal control36. Primer sequences were as previously described37. 
An unpaired two-tailed Student’s t-test was performed to assess statistical differ-
ences on ∆Ct values of each condition, with a significance threshold of 0.05.
In situ hybridization of proteolipid protein (Ppl1) mRNA on paraformalde-
hyde-fixed CNS tissue was performed as previously described38. The plasmid 
containing a fragment of 801-bp Plp cDNA was provided by Prof I. Griffith 
(University of Glasgow). Briefly, sections were incubated with digoxigenin-labeled 
complementary RNA probes at 65 °C overnight and subjected to a standard wash 
protocol (50% formamide, 1× standard saline citrate, 0.1% Tween-20, 65 °C, 
3 × 30 min) to remove nonspecific probe binding. The target bound probes were 
detected by alkaline phosphatase-conjugated anti-digoxigenin antibody (Roche 
Applied Science, cat. no. 11093274790) and visualized as purple precipitate after 
incubation in NBT/BCIP solution according to the manufacturer’s instructions 
(Roche, Lewes, UK). The slides were dehydrated with ascending concentration of 
ethanol, cleared with xylene and mounted in dibutyl phthalate in xylene. Images 
were acquired with the Zeiss Axio Observer microscope.
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t cell culture. CD4+ T cells were immunomagnetically purified by negative selec-
tion (Stem Cell Technologies) from splenocytes of male and female C57BL/6 mice 
6–14 weeks old and cultured in RPMI 1640 (Life Technologies) supplemented 
with 10% FCS, 1% penicillin/streptomycin, 1% l-glutamine, 1% HEPES, 1% 
sodium pyruvate, 1% nonessential amino acids and 50 nM β-mercaptoetha-
nol (all Life Technologies). In Supplementary Figure 3d, naive CD4+ T cells 
were purified using EasySep Mouse Naive CD4+ T cell Isolation Kits (Stem Cell 
Technologies). T cells were activated with plate-bound anti-CD3 (1 µg/mL, clone 
145-2C11) and soluble anti-CD28 (1 µg/ml, clone 37.51), both from eBioscience, 
for 3 d in nonpolarizing (no exogenous cytokine) or Treg-polarizing conditions 
consisting of rhTGF-β (2 ng/mL, R&D Systems), rhIL-2 (10 ng/mL, eBioscience) 
and anti-IFN-γ (10 µg/mL, clone XMG1.2, Bioxcell). T cells were then reactivated 
in brain slice medium (described below) for a further 72 h, and conditioned 
media were harvested. Polarization of all cultures was verified by flow cytometry, 
and Treg cultures used for experiments generally consisted of 80–90% Foxp3+  
T cells (see Supplementary Fig. 2f). For CCN3 immunoblotting, depletion and 
elution, cells were reactivated in serum-free X-VIVO 15 medium (Lonza).
For adoptive transfer experiments, nTreg were immunomagnetically purified 
(Stem Cell Technologies) by negative selection of CD4+ T cells followed by posi-
tive selection of CD25+ cells from splenocytes and lymph nodes of C57BL/6 mice. 
For i.p. injection, cells were resuspended at 5 × 106 cells/mL in saline.
organotypic brain-slice culture. Brainstem slices (300 µm) from male and female 
P0–2 C57BL/6 mice were prepared using a McIlwain Tissue Chopper and cul-
tured in transwell inserts with brain-slice medium consisting of 46.6% minimum 
essential medium, 25% Earle’s balanced salt solution, 25% heat inactivated horse 
serum, 1% penicillin/streptomycin, 1% glutamax (Life Technologies) and 1.4% 
d-glucose (Sigma). Slices were treated with 5% T cell-conditioned media and/or 
anti-CCN3 (10 µg/mL; clone 231216, R&D Systems), isotype control (clone 54447, 
R&D Systems) and/or eluate from immunoprecipitation every other day for the 
period defined. For remyelination studies, brainstem slices were demyelinated 
after 14 d in culture with lysolecithin (0.5 mg/ml, Sigma) for 16 h. Slices were 
washed and allowed to remyelinate for up to 14 d. For co-culture studies, 1.7 × 
104 FACS-purified natural Treg from Foxp3-eGFP mice were added directly on to 
brain stem slices in a volume of 10 µL (Supplementary Fig. 2a).
Staining of organotypic brain slices. Slices were fluorescently stained for myelin 
basic protein (MBP; 1:600, clone 12, Millipore) and axonal neurofilament-200 
(NF200; 1:200, clone RT97, Millipore). After fixation in 4% paraformaldehyde 
for 45 min at RT, slices were blocked and permeabilized at RT for 1 h in 3% heat-
inactivated horse serum (Life Technologies), 2% bovine serum albumin (Sigma) 
and 0.5% Triton X-100 (Sigma). Both primary and secondary antibodies (goat 
anti-rat AF594, cat. no. A11007; goat anti-mouse AF488, cat. no. A11001; and 
goat anti-mouse AF405 cat. no. A31553, 1:500; all from Life Technologies) were 
incubated overnight at 4 °C. Slices were mounted with ProLong Gold Antifade 
(Life Technologies) and imaged with a Leica TCS SP5 confocal microscope at 
0.5-µm intervals over 10 µm, taking up to five fields of view (FOV) per slice, 
dependent on slice size. Representative images were displayed with a green lookup 
table (LUT) for NF200 and red LUT for MBP, applied using Leica AF software.
electron microscopy of organotypic brain slices. Slices were immersion fixed 
in 4% PFA/2% glutaraldehyde in 0.1 M phosphate buffer for 24 h, washed in 
phosphate buffer and postfixed in 1% osmium tetroxide in 0.1 M phosphate 
buffer for 45 min. Samples were dehydrated in increasing concentrations of 
acetone and embedded in Araldite resin. Ultrathin 60 nm sections were stained 
in uranyl acetate and lead citrate and then viewed in a JEM1400 Transmission 
electron microscope (JEOL). To count the percentage of myelinated fibers per 
unit area of slice (at least 600 µm2/condition), three photographs were taken from 
random, non-overlapping fields from each of 3 slices per condition and analyzed. 
To measure g-ratios, at least 35 randomly chosen axons from each of 3 slices per 
condition were analyzed by tracing the axonal circumference and the whole fiber 
circumference (using a graphics pad and pen). G-ratios were calculated by divid-
ing these values, and data were analyzed using one-way ANOVA with Bonferroni 
post hoc tests, with P < 0.05 considered significant.
mixed glial cultures. Mixed glial cells were generated from male and female P2–7 
C57BL/6 pups according to the manufacturers’ protocol for the Neural Tissue 
Dissociation Kit (P) (Miltenyi Biotec). In short, brains were dissected, cerebel-
lum and meninges were removed, and tissue was dissociated via mechanical and 
papain enzyme digestion before filtration through a 40-µm strainer. Cells were 
plated in poly-L-lysine-coated (10 µg/ml, Sigma) 96-well flat, glass-bottomed 
plates (BD Falcon) at a density of 105 cells per well, and cultures were maintained 
at 37 °C, 5% CO2. Cells were cultured for 5 d in DMEM (Life Technologies) sup-
plemented with PDGFαα (10 ng/mL; PeproTech), 10% endotoxin-free FCS, 1% 
penicillin/streptomycin and 1% l-glutamine (Life Technologies). Cells were cul-
tured for a further 2 d in neural medium (Miltenyi Biotec) supplemented with 1% 
penicillin/streptomycin, 1% l-glutamine, 2% B27/MACS Neuro Brew21 (Miltenyi 
Biotec) and PDGFαα (10 ng/ml; PeproTech). At day 7 in culture, PDGFαα was 
withdrawn to allow oligodendrocyte differentiation, and cells were stimulated 
with 5% Treg-conditioned media, rCCN3, anti-CCN3 (clone 231216) or isotype 
control (clone 54447), all from R&D Systems, or controls for up to 5 d.
Immunofluorescence staining of mixed glial cultures. Cell cultures were fixed 
in 4% paraformaldehyde (pH 7.4) for 15–20 min at RT and blocked in 10% nor-
mal goat serum with 0.1% Triton X-100 for 1 h. Cells were then incubated with 
primary antibody overnight at 4 °C and with secondary antibodies for 1 h at RT. 
Cells were counterstained with DAPI for 5 min at RT. Primary antibodies used 
were rabbit anti-mouse Olig2 (1:200; cat. no. AB9610, Millipore), rat anti-mouse 
MBP (1:200; clone 12, Millipore), rat anti-mouse Ki67 (1:200; clone SoIA15, 
eBioscience), rabbit anti-mouse GFAP (1:200; cat. no. Z0334, Dako) and rat anti-
mouse CD11b (1:200; clone M1/70, eBioscience); and secondary antibodies used 
were goat anti-rabbit AF488 (1:1,000; cat. no. A-11008) and goat anti-rat AF594 
(1:1,000; cat. no. A-11007), both from Life Technologies. For live/dead staining, 
unfixed cells were stained using the LIVE/DEAD® Viability/Cytotoxicity Kit for 
mammalian cells (Life Technologies). Immunofluorescence was detected using 
an EVOS microscope at 10× magnification and n = 6 wells per condition, with 
one mean value from multiple images calculated for each well.
oPc purification. Immunopanning purification of OPC was performed as previ-
ously described39. Briefly, OPC were purified from male and female P7–9 mouse 
brain cortices. Tissue culture dishes were incubated overnight with goat IgG and 
IgM secondary antibodies to mouse (cat. no. 115-005-004, Jackson Laboratories) 
in 50 mM Tris-HCl at a final concentration of 10 µg/mL, pH 9.5. Dishes were 
rinsed and incubated at room temperature (RT) with primary antibodies for 
Ran-2, GalC and O4 from hybridoma supernatants39. Rodent brain hemispheres 
were diced and dissociated with papain (Worthington) at 37 °C. After trituration, 
cells were resuspended in a panning buffer (0.2% BSA in DPBS) and incubated at 
RT sequentially on three immunopanning dishes: Ran-2 and GalC were used for 
negative selection before positive selection with O4. OPC were released from the 
final panning dish using 0.05% Trypsin (Invitrogen). OPCs were typically 95% 
pure after immunopanning, with a viability of 94%.
oPc–dRg co-cultures. OPC–DRG co-cultures were prepared as previously 
described39. Briefly, DRG neurons from E15 Sprague-Dawley rats were dissoci-
ated, plated (150,000 cells per 25-mm cover glass) and purified on collagen-
coated coverslips in the presence of 100 ng/mL NGF (AbD Serotec). Neurons 
were maintained for 3 weeks and washed with DMEM (Invitrogen) extensively 
to remove any residual NGF before seeding OPC. Co-cultures were grown in 
chemically defined medium composed of DMEM (Invitrogen) supplemented 
with B27 (Invitrogen), N2 (Invitrogen), penicillin-streptomycin (Invitrogen), 
N-acetyl-cysteine (Sigma-Aldrich) and forskolin (Sigma-Aldrich).
ccn3 quantification and depletion. Proteome profiling of conditioned media 
was performed using an Angiogenesis Antibody Array (R&D Systems) as per 
the manufacturer’s instructions and identified CCN3 as a candidate protein of 
interest. Levels of CCN3 in T cell-conditioned media were quantified by ELISA 
(R&D Systems) according to the manufacturer’s instructions.
Treg-conditioned media were depleted of CCN3 using monoclonal anti-CCN3 
antibody-coupled magnetic beads (clone 231216, R&D Systems and Thermo 
Scientific) or isotype control-coupled beads (clone 54447, R&D Systems). 
Coupling of antibody and beads was performed according to the manufactur-
ers’ instructions. In short, 1 mg of beads was incubated with 500 µg/mL of anti-
body solution, and the flow-through was analyzed by spectrophotometry. For 
immunoprecipitation, up to 1 mL of Treg-conditioned media was added to 1 mg 
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of monoclonal antibody-coupled magnetic beads and incubated on a rotator at 
RT for 2 h, with additional vortexing of the samples every 15 min to ensure that 
the beads remained in suspension. The samples were then placed in a magnetic 
stand and CCN3-depleted Treg-conditioned media and isotype-treated controls 
were collected. To elute Treg-derived CCN3, beads were washed and elution buffer 
(0.1 M glycine, pH 2.0) was added for 3–5 min at RT. To neutralize the low pH 
of the solution, neutralization buffer (1 M Tris, pH 7.4) was immediately added, 
samples were placed on a magnetic stand and the eluate containing Treg-derived 
CCN3 was collected and resuspended in medium according to the initial vol-
ume. Eluted product from anti-CCN3-coated and IgG-coated beads was added 
to brain-slice cultures as indicated.
Immunoblotting of ccn3. T cell-conditioned media or recombinant CCN3 
(R&D Systems) were enriched for CCN3 using heparin-sepharose beads as previ-
ously described40. In short, up to 10 mL of Treg-conditioned media (equivalent 
to 25 ng of CCN3) or recombinant CCN3 were added to 100 µL 50% heparin- 
sepharose slurry and incubated on a rotator at 4 °C overnight. Fifty µL of 
PBS-washed CCN3-bound heparin-sepharose beads were boiled and added 12.5 µL 
of 5× reducing loading dye for 10 min before loading on a reducing 15% SDS-
PAGE. Following transfer onto PVDF membrane (Millipore) and blocking (3% 
BSA in PBS/1% Tween) for 1 h at RT, protein was probed using polyclonal anti-
CCN3 antibody (1:1,000; cat. no. AF1976, R&D Systems) overnight at 4 °C and 
secondary anti-goat HRP (1:3,000; cat. no. sc-2020, Santa Cruz) for 1 h at RT.
Image analysis and data processing. Customized ImageJ41 plugins were used to 
assist quantifying positively stained cells and areas in all models.
Regions of interest corresponding to spinal cord lesions were initially drawn 
using the polygon tool. Regions were subsequently refined based on the local cell 
density by thresholding a Gaussian-smoothed duplicate of the DAPI channel to 
give a more detailed contour, which was corrected manually if necessary using 
a brush selection tool. Cells were then counted manually within the lesion; in 
some cases, counts were automatically initialized as localized regions of high 
fluorescence detected by the ‘find maxima’ command in ImageJ before manual 
verification and correction to ensure that all regions contributing to the final 
counts were consistent with expected cell morphology (i.e., no artifacts). ImageJ 
plugins were written to perform the lesion refinement and to assist with manual 
cell counting.
Myelination index was used for overlapping myelin and axonal markers in 
3D, indicating (re)myelination. Confocal z-stacks of brain slices, both red (MBP) 
and green (NF200) channels, were preprocessed by first smoothing with a 3D 
isotropic Gaussian filter (sigma = 0.5 µm) before subtracting a background esti-
mate created by applying a 3D morphological opening (filter radius = 1 µm). 
The processed channels were then thresholded, with the threshold determined 
automatically by implementing the ‘triangle’ method in ImageJ. The overlap coef-
ficient was determined as the proportion of above-threshold pixels in the green 
channel that were also detected in the red channel, which quantified MBP signals 
colocalizing with NF200 signals. An ImageJ plugin was written to fully automate 
the above steps. MBP+ oligodendrocytes were counted manually.
Cell counts of Olig2+, MBP+ and Ki67+ cells in mixed glial cultures were 
performed manually. MBP+ areas were determined from the number of above-
threshold pixels after applying a small median filter (radius = 1.5 pixels), followed 
by subtracting a background image generated by the ‘subtract background’ com-
mand in ImageJ (sliding paraboloid option, radius = 100 pixels). For each plate, 
the threshold was determined and the same threshold was applied to all ana-
lyzed images within each experiment. An ImageJ plugin was written to automate 
the above steps. Plugin codes will be made publically available on the Queen’s 
University Belfast website.
experimental designs and statistical analyses. No statistical methods were used 
to predetermine sample sizes, but our sample sizes were similar to those reported 
in previous publications3,15,39. For in vivo studies, any animal that reached 
a predefined welfare limit before the analysis timepoint was excluded from the 
study. For organotypic brain slice experiments, slice integrity was determined 
by neurofilament 200 (NF200) staining before analysis. Animals and brain slices 
were randomly assigned to experimental groups at the beginning of experiments. 
Myelination indices (brain slices) and MBP area (glial cultures) were blindly 
assessed by a computer program and in an identical manner for all files. MBP+ 
cell counts in brain slices were performed by independent observers on ran-
domly selected images from z-stacks. For all other studies, data collection and 
analyses were not performed blind to the conditions of the experiments. Datasets 
were tested for normal distribution, variances and statistical significance using 
unpaired two-tailed Student’s t-tests for parametric data with or without Welch 
corrections, or using Mann-Whitney U-tests for nonparametric data, as detailed 
in figure legends. Normality of datasets was tested using the KS or D’Agostino-
Pearson omnibus normality test methods. Where n was not sufficient for normal-
ity testing, non-normal distribution was assumed and nonparametric statistical 
testing was used. All statistical analysis and graphing of data were performed 
using GraphPad Prism. Species validation information for antibodies can 
be obtained from the commercial suppliers indicated.
A Supplementary methods checklist is available.
data and code availability. The data and analysis code that support the 
findings of this study are available from the corresponding author upon 
reasonable request.
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